RT @Yuz6Yusof: #EULAR2023 #LB0003 It is unheard of therapies that potentially can improve Sjogren patients with high sym
Tweet Content
#EULAR2023 #LB0003 It is unheard of therapies that potentially can improve Sjogren patients with high symptoms burden. Phase 2 RCT of Dazodalibep (CD40L-i) showed ESSPRI improved vs PBO. Numerical improvement in other secondary (Fatigue). Will await results in Phase 3 @RheumNow https://t.co/0NzR83apeY
Show on Archive Page
On
Display in Search Results
On
PDQ
Off